XNCR

Latest SEC Filings & News for XNCR

1 most recent filing and news item mentioning XNCR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/XNCR/news?limit=20"

Pull XNCR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Positive

Xencor announces Phase 1 expansion data in renal cell carcinoma and opens healthy subject study for lead bispecific antibody.

Xencor reported Q2 2026 financial results and announced that data from XmAb819 expansion cohorts in clear cell renal cell carcinoma will be presented at ESMO 2026; additionally, the company initiated a first-in-human study for its first xenlock bispecific antibody, XmAb412.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.